“While AdvaMed is still reviewing the details of the BAH report, we are pleased that the report’s recommendations support the association’s long-held priorities on the need to improve the consistency in decision-making throughout FDA’s review process and to enhance reviewer training and management oversight within the agency’s device center."
Participants in the roundtable noted that sustaining this positive impact requires the right public policies to support value creation and continued investment in research and development – the kind of investment that helps grow high-technology manufacturing jobs in America.
The award, sponsored by PwC, is given annually to an individual who has demonstrated outstanding leadership in the advancement of ethics and ethical behavior in the medical device and diagnostics industry.
Key policy issues in China include the need to streamline regulations, ensure appropriate reimbursement for medical technologies and harmonize ethical business practices.“Our efforts in China will help ensure patient access to advanced medical technologies and will benefit both local Chinese companies and importers,” Ubl said.
“AdvaMed commends the House for voting to make permanent the research and development tax credit, which will encourage R&D work here in America. R&D is the lifeblood for innovation and a critical element to growth and maintaining America’s leadership in the medtech sector.
“The medical technology industry has no shortage of issues to address on Capitol Hill – from repeal of the medical device tax to FDA oversight to payment reforms – and Riley’s deep government and health care experience will help the association advance its advocacy goals.”
“AdvaMed commends the committee for taking action to address certain expiring provisions of the tax code that are important to medical technology innovators"
“AdvaMed is committed to comprehensive tax reform which we believe is essential to job creation and continued economic growth..."
The Advanced Medical Technology Association (AdvaMed) today announced that José “Joe” E. Almeida, Chairman, President and CEO of Covidien, has been named chairman of the AdvaMed Board of Directors for a two-year term.
The Advanced Medical Technology Association (AdvaMed) released the following statement by JC Scott, senior executive vice president, government affairs, on the bipartisan legislation introduced to repeal the Medicare sustainable growth-rate (SGR) formula: